Biocare Co., Ltd.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Biocare Co., Ltd..The latest application filed is for "novel use of panduratin derivatives or an extract of boesenbergia pandurata for enhancing muscle mass growth, fighting fatigue, and enhancing exercise performance".

Company Profile

0.6.5

Biocare Co., Ltd. - Seoul N/A KR
Biocare Co., Ltd.; - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of panduratin derivatives or an extract of Boesenbergia pandurata for enhancing muscle mass growth, fighting fatigue, and enhancing exercise performance Grant 9,452,193 - Hwang , et al. September 27, 2	2016-09-27
Novel Use Of Panduratin Derivatives Or An Extract Of Boesenbergia Pandurata For Enhancing Muscle Mass Growth, Fighting Fatigue, And Enhancing Exercise Performance App 20150374777 - HWANG; Jae-Kwan ; et al.	2015-12-31
Use of panduratin derivatives or an extract of Boesenbergia pandurata for promoting muscle mass growth, fighting fatigue, and enhancing exercise performance capability Grant 9,198,880 - Hwang , et al. December 1, 2	2015-12-01
Use of lignan-type compounds or extract of nutmeg or aril of nutmeg comprising the same Grant 8,969,408 - Hwang , et al. March 3, 2	2015-03-03
Novel Use Of Panduratin Derivatives Or An Extract Of Boesenbergia Pandurata For Promoting Muscle Mass Growth, Fighting Fatigue, And Enhancing Exercise Performance Capability App 20130344182 - HWANG; Jae-Kwan ; et al.	2013-12-26
Use of lignan compound for anti-wrinkle treatment Grant 8,435,957 - Hwang , et al. May 7, 2	2013-05-07
Use Of Lignan Compound For Anti-wrinkle Treatment App 20120288579 - Hwang; Jae-Kwan ; et al.	2012-11-15
Novel Use Of Lignan-type Compounds Or Extract Of Nutmeg Or Aril Of Nutmeg Comprising The Same App 20110118346 - Hwang; Jae Kwan ; et al.	2011-05-19
Suppressant Of Toxicity Induced By Cancer Chemotherapeutic Agent And Composition Of Cancer Chemotherapeutic Agent Containing The Same App 20090156688 - Park; Kwang-Kyun ; et al.	2009-06-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.